The UK Committed £58 Billion to Research. Here Is What It Did Not Buy.
Faraz Rizvi is a UK operator-practitioner writing about the work between a research breakthrough and a fundable company. He runs SpinUp Forge. Foundry is SpinUp Forge's custom agentic harness.
If you are about to spin a company out of a UK university, the number that should shape your plan is not £58.5 billion. The country committed £58.5 billion to research over four years and ring-fenced roughly £8 million a year to help spinouts cross from a lab result to a term sheet — and it is that second number, not the first, that describes your next two years. The headline figure is what the science is worth to the state. The £8 million is what the crossing is worth to it: almost nothing. Read that ratio as instruction, not insult. The system has decided the discovery is the hard part it will pay for, and the company is the part you are on your own for.
Both figures are real. The £58.5 billion is the DSIT R&D spending plan to 2029/30. The roughly £8 million a year is the Autumn Budget 2024 ring-fence for spinout proof-of-concept support — £40 million over five years, delivered not as a block grant shared out across universities and their technology transfer offices (TTOs, the units that turn research into licences and companies) but as a single national competitive scheme: its recent rounds have run at about £9 million each, and the 2025 round funded roughly 48 projects from around 2,700 applications.
The clearest way to see the gap is by area, not in a sentence. UKRI holds the largest share of that £58.5 billion — £38.6 billion, about two-thirds. The first treemap sizes UKRI's own 2026/27 budget by its four big buckets; innovation and commercialisation is the smallest of them, and it is where spinout money lives. The second opens that bucket up. The £8 million that reaches spinout proof-of-concept support nationally is the ember band at the foot of it. Look at the area. That is the policy.
The top of the funnel is being narrowed
The science budget that produces spinouts is being quietly held flat — while the system asks the bottom of the funnel to produce more.
Here is a question worth asking before you build a plan around grant funding: is the money that feeds spinouts growing, or shrinking? The honest answer is shrinking, in the place that matters most. Curiosity-driven research — the open-ended, investigator-led science that spinouts are built from — is held at flat cash through to 2030, which is a real-terms cut once inflation is applied (Cambridge IIP, 2026; confirmed by Research Professional News). The top of the funnel is being narrowed at the same moment the bottom is asked to produce more companies.
What that data doesn't show is why the narrowing is hard to reverse — and the why is the part that should change how you behave. Tim Harper, in his analysis of the UKRI budget, named it: "Universities still largely reward being cited, not being manufactured. The safest academic career path is usually another paper and another grant, not a risky spin-out that might fail." The National Audit Office reached adjacent ground from the opposite chair, formally questioning whether the grant-based model is delivering on growth (NAO HC 875, May 2025). A critic and an auditor, pointing at the same gap.
For you, the lesson is unsentimental: the institution around you is not built to push you out the door. Capacity workarounds exist — Wessex's CCF-RED model, UAL's on-demand commercialisation support — and they can move your spinout forward. None of them changes the incentive structure above the TTO. Plan as if the help is real but the tailwind is not.
The state has changed what your pound buys
Innovate UK has stopped being a grants window and become an account-managed pathway — and the entry ticket is operational maturity you are expected to already hold.
The bigger question is not how much money exists, but what it now asks of you to get it. The answer changed this year. Innovate UK's Velocity restructuring — announced March 2026, now entering implementation — replaces open grant competitions with an account-managed pipeline across six priority sectors, positioning Innovate UK as a "trusted due diligence engine" rather than a funding lottery (UKRI, March 2026). The shift is not cosmetic. The state no longer offers you a chance at funding; it offers a relationship with the body that validates your readiness before it walks you to capital — and it expects board governance, financial controls, a product roadmap, and go-to-market clarity to be in place before that conversation, not after.
You can read the programmes themselves as a confession of where the gap is. The Innovate UK Venture Builder Pilot offers £150,000 per spinout from October 2026, and its stated purpose is to "close the gap between validated customer discovery and investment readiness" — funding investability, explicitly not further technical milestones. Government has written the execution gap into the eligibility rules. At the same time every TTO in the country is absorbing a legal-scaffolding change, the new IP-transfer exemption that came into force on 30 April 2026 (SI 2026/369). This is a system mid-transition — which is exactly when knowing the new rules early is worth the most.
So is there money out there for you? Yes — and that is the trap. At seed, the UK is genuinely strong: spinouts raised nearly £2 billion in 2025. But more than a third of those rounds were under £500,000, the funding thins sharply above seed, and roughly 70% of it sits in London and the Oxford–Cambridge corridor (Beauhurst, 2026; geography per Success Knocks, 2026). Cambridge IIP says the underlying thing plainly: research excellence "doesn't automatically translate into industrial competitiveness." Read that as a warning about your second year, not your first. The round that kills good spinouts is rarely the seed. It is the one after — when the science is proven and the company still is not legible to a growth investor. (Full deal-size and geography breakdowns are in the evidence note below.)
One more number tells you which argument is now winnable and which is not. The average university equity stake in spinouts fell to 16.1% in 2024, the lowest in at least a decade, and more than 50 universities have adopted the USIT/Tracey guidelines (RAEng/Beauhurst, Spotlight on Spinouts 2025). The terms fight — who owns what — is converging toward resolution. The fight that is still open, and the one the new policy money is aimed at, is throughput: how fast and how cheaply you can incorporate, licence the IP, hire, and become investable once the terms are agreed.
The cost of crossing the gap just changed too
The argument is not that spinouts need more money. It is that the same operator pound now buys a result it could not buy in 2024 — and the funding rules have not caught up.
Here is the part I would not have said with confidence a year ago: the same operator-cost pound now buys a materially different result than it did in 2024. An operator working against codified agentic workflows is not bringing 2024-vintage output to the role — Piece 2 sets out that evidence in full. Which makes one small policy change carry unusual weight. If I could move a single number inside the Venture Builder Pilot, I would ring-fence 10–25% of the £150,000 as a named operator-cost line: explicit permission to spend it on a non-academic operator rather than on further technical milestones. No new legislation, no new programme — just a decision that the gap between a validated finding and an investable company is partly a management problem, not only a science one. Piece 3 walks through what that operator actually does in a spinout's first 18 months. The programme designs already hint the policymakers know this. The unit economics have not caught up.
The funding system has changed its question. Most of the infrastructure around it — and most of the founders walking into it — are still answering the old one.
Sources
- DSIT Research and Development Plans to 2029/30, GOV.UK
- UKRI, Explainer: budget allocations for UK research and innovation (2026/27–2029/30)
- Cambridge IIP Executive Summary 2026
- Cambridge IIP UK Innovation Report 2026
- CIIP, UK Innovation Report 2026 published as industrial strategy enters delivery phase
- Tim Harper, UKRI Budget 2025-26 Analysis
- Research Professional News, Flat cash for curiosity-driven research at UKRI to 2030
- National Audit Office HC 875, UKRI: Providing Support Through Grants (May 2025)
- Beauhurst, Investment into Spinouts 2026
- RAEng/Beauhurst, Spotlight on Spinouts 2025
- Royal Academy of Engineering, UK top European deep-tech hub but weak at late-stage investment
- UKRI, Innovate UK Venture Builder Pilot: Expression of Interest
- UKRI, New plan to help the next generation of tech businesses thrive (Velocity, March 2026)
- ARIA, Become an Activation Partner (Cohort 2)
- SI 2026/369, Technology Transfer from Businesses and Educational Organisations
- Success Knocks, Analysis of Venture Capital Trends UK 2026
Evidence note
- The shape of the £1.96bn: spinouts raised £1.96 billion across 384 deals in 2025; 36.7% of those fundraisings were under £500,000; only 57 UK spinouts have ever raised €20–29.9m, and 42 at €30–39.9m (Beauhurst, 2026). The UK is the top European deep-tech hub but weak at late-stage investment (RAEng).
- Research input vs industrial output: the UK ranks fourth globally for scientific publications and spends 2.68% of GDP on R&D (Cambridge IIP, 2026) — strong inputs, structurally weak outputs.
- Geography: approximately 45% of UK venture investment sits in London and a further ~25% in the Cambridge/Oxford/Brighton corridor (~70% combined). Deep-tech VC is approximately 12% of all UK VC (Success Knocks, 2026).
- The frontier is moving toward translational infrastructure: ARIA's Activation Partners Cohort 2 — £100m envelope, new AI-in-Science pillar — closed applications 21 May 2026.
- Venture Builder Pilot eligibility: applicants must have completed the ICURe Exploit gate (ICURe funds academics to test commercial hypotheses); prior external funding must not exceed £100,000; the stage-2 programme runs nine months and funds investability-building only.
- Budget bucket names: the four top-level buckets follow UKRI's Delivery Plan 2026-27 goal totals (curiosity-driven/discovery research £3.653bn; strategic priorities £1.924bn; system foundations / cross-cutting infrastructure £2.004bn; company support / innovation & commercialisation £1.638bn). The £1.924bn "strategic priorities" bucket funds the government-priority portfolio — the Industrial Strategy sectors and the five Missions; the dedicated R&D Missions Accelerator within it is about £50m in 2026-27 (£500m across the Spending Review), so the bucket should not be read as the Missions programme alone.
- Method and caveats: the roughly £8m/yr spinout proof-of-concept ring-fence is the £40m-over-five-years spinout Proof-of-Concept Fund announced at the Autumn Budget 2024 (so ~£8m/yr is the five-year average), delivered by UKRI as the competitive UKRI Translation: Proof of Concept scheme; its rounds have run at about £9m, and the 2025 round was heavily oversubscribed (~48 awards from ~2,700 expressions of interest, per Research Professional, Feb 2026); the internal split of the £1.64bn innovation bucket is indicative, since UKRI's tables do not itemise Velocity, HEIF, or spinout support separately, and the £8m band is widened in the zoom view to stay legible; geographic VC-concentration figures are approximate.